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Feeding dietary supplements containing trans-10, cis-12-conjugated linoleic acid (t10,c12-CLA) has been shown to induce milk
fat depression in cows, ewes and goats. However, the magnitude of the response is apparently less pronounced in lactating goats.
The objective of this study was to evaluate the effects of increasing doses of CLA methyl esters (CLA-ME) on milk production,
composition and fatty-acid proﬁle of dairy goats. Eight Toggenburg goats were separated in two groups (four primiparous and
four multiparous) and received the following dietary treatments in a 4× 4 Latin Square design: CLA0: 45 g/day of calcium salts of
fatty acids (CSFA); CLA15; 30 g/day of CSFA+ 15 g/day of CLA-ME; CLA30: 15 g/day of CSFA+ 30 g/day of CLA-ME; and CLA45:
45 g/day of CLA-ME. The CLA-ME supplement (Luta-CLA 60) contained 29.9% of t10,c12-CLA; therefore, the dietary treatments
provided 0, 4.48, 8.97 and 13.45 g/day of t10,c12-CLA, respectively. Feed intake, milk production, concentration and secretion of
milk protein and lactose, body condition score and body weight were unaffected by the dietary treatments. Milk fat secretion was
reduced by 14.9%, 30.8% and 40.5%, whereas milk fat concentration was decreased by 17.2%, 33.1% and 40.7% in response
to CLA15, CLA30 and CLA45, respectively. Secretions of both de novo synthesized and preformed fatty acids were progressively
reduced as the CLA dose increased, but the magnitude of the inhibition was greater for the former. There was a linear reduction in
most milk fat desaturase indexes (14:1/14:0, 16:1/16:0, 17:1/17:0 and 18:1/18:0). Milk fat t10,c12-CLA concentration and secretion
increased with the CLA dose, and its apparent transfer efﬁciency from diet to milk was 1.18%, 1.17% and 1.21% for CLA15,
CLA30 and CLA45 treatments, respectively. The estimated energy balance was linearly improved in goats fed CLA.
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Implications
A number of studies have shown that conjugated linoleic acid,
such as bioactive fatty acid, causes reduced milk fat synthesis
and changes the milk fatty-acid composition in different
ruminant species. These changes may be accompanied by an
improvement in energy balance, suggesting that the energy
spared for milk fat synthesis can be used to replenish body
reserves in lactating goats.
Introduction
Dietary fatty acids may be used to modulate animal metabo-
lism for speciﬁc purposes (Salter and Tarling, 2007), and certain
conjugated linoleic acid (CLA) isomers represent a remarkable
example of such application. The trans-10, cis-12-conjugated
linoleic acid (t10,c12-CLA) isomer has been shown to reduce
milk fat secretion in lactating cows, which is a consequence
of a coordinated inhibition of gene expression for lipogenic
enzymes in the mammary gland (Baumgard et al., 2002b). This
anti-lipogenic effect of t10,c12-CLA may be advantageous in
certain situations as the energy spared for milk fat synthesis
could result in increased milk production and secretion of milk
protein and/or an improvement in the energy balance (EB) of
lactating cows (Bauman et al., 2011).
There are different forms to provide t10,c12-CLA to rumi-
nants. Supplying it as methyl esters is more advantageous
for commercial production as compared with free fatty acids,
calcium soaps or lipid-encapsulated forms. Methyl esters
can be hydrolyzed and biohydrogenated by ruminal bacteria
(Maia et al., 2010) and it does not alter post-ruminal diges-
tion (de Veth et al., 2004). The effects of dietary t10,c12-CLA
has been shown to be dose-dependent in lactating cows
(de Veth et al., 2004), but such response has not been fully† E-mail: dimas.oliveira@udesc.br
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addressed in goats. Limited evidence indicates that goats are
less sensitive to the anti-lipogenic effects of t10,c12-CLA
when compared with cows, indicating possible inter-species
differences (Shingﬁeld et al., 2009). The objective of this study
was to evaluate the effects of increasing doses of a rumen-
unprotected CLA supplement (containing t10,c12-CLA as
methyl esters) on milk production, milk composition, milk
fatty-acid proﬁle and EB in dairy goats. To the best of our
knowledge, this is the ﬁrst study to address the dose–response
effects of a rumen unprotected t10,c12-CLA supplement in
lactating goats.
Material and methods
Animals, design and treatments
Ethics Committee on Animal Experimentation and animal
handling of the Santa Catarina State University approved
all procedures. Eight non-pregnant Toggenburg goats were
divided in two groups according to the body weight, milk
production and lactation number (four primiparous and
four multiparous) and randomly assigned to the dietary
treatments in a two 4× 4 Latin Square Design with 12-day
treatment periods separated by 6-day washout intervals
(to minimize possible residual effects). At the beginning of
the study, the animals were in mid-lactation (135, s.d. ±
21 days in milk), with average body weight of 46.7 kg
(s.d. ± 4.8), body condition score (BCS) of 2.5 and milk
production of 2.62 kg/day (s.d. ± 0.5). The animals were
maintained in individual stalls with ad libitum access to
water and a mineral supplement.
Goats were individually fed the following dietary treatments:
(1) Control–CLA0: 45 g/day of calcium salts of fatty acids
(CSFA); (2) CLA15: 30 g/day of CSFA+ 15 g/day of CLA methyl
esters (CLA-ME); (3) CLA30: 15 g/day of CSFA+ 30 g/day of
CLA-ME; and (4) CLA45: 45 g/day of CLA-ME. The CLA-ME
supplement (Luta-CLA 60, BASF, São Paulo, São Paulo,
Brazil) contained 29.9% of t10,c12-CLA (Table 1); therefore,
the dietary treatments provided 0, 4.48, 8.97 and 13.45 g/
day of t10,c12-CLA, respectively. The CSFA (Megalac-E,
Church & Dwight, Nova Ponte, Minas Gerais, Brazil) con-
taining linoleic acid as the major fatty acid (Table 1), and it
was used as a control lipid in the study. The lipid supple-
ments were mixed with the concentrate.
The CLA30 dose of t10,c12-CLA was based on data
reported by Lock et al. (2006) where, on a metabolic
weight basis, ∼0.4 g/day of t10,c12-CLA was expected
to reach the abomasum, reducing the milk fat secretion by
20% to 25%. In addition, a rumen biohydrogenation of
95% for CLA-ME was assumed to occur (Jenkins et al., 2008).
The nutrient requirements were calculated according to
the National Research Council (NRC) (2007) and the diet
formulations were carried out using the Small Ruminant
Nutrition System (Tedeschi et al., 2010). The concentrate
was formulated to meet the nutritional requirements in
relation to that supplied by corn silage (ad libitum fed;
Table 2).
Experimental procedure
The animals were individually fed corn silage (ad libitum) plus
1 kg of concentrate. The concentrate was provided in equal
proportion after the morning (0.5 kg) and afternoon (0.5 kg)
milking to ensure a complete intake of the supplemental fatty
acids. Corn silage orts were weighed daily to calculate silage
Table 1 Fatty-acid composition (g/100 g fatty acids) of lipid supplements
Supplement
Fatty acids Control1 Luta CLA-602
4:0 to 11:0 0.67 nd
12:0 2.85 nd
14:0 1.12 nd
c9-14:1 0.01 nd
15:0 0.06 nd
16:0 17.09 4.10
c9-16:1 0.21 nd
17:0 0.15 nd
c9-17:1 0.06 nd
18:0 6.65 3.60
t4 to t16 18:1 4.76 nd
c9-18:1 18.64 27.40
c11 to c13 18:1 2.33 nd
Non-conjugated 18:2 isomers 0.84 nd
c9,c12-18:2 35.32 1.20
c9,c12,c15-18:3 3.09 nd
c9,t11-CLA 0.16 29.80
t9,c11-CLA 0.07 nd
t10,c12-CLA nd 29.90
∑LCFA 1.49 nd
∑Unidentiﬁed 4.52 3.00
nd = not detected;∑LCFA = sum of all fatty acids with chain length equal to
or higher than 18 carbons.
1Control: calcium salts of long-chain fatty acids.
2Luta CLA-60: supplement containing 29.9% of methyl ester of t10,c12-CLA.
Table 2 Concentrate composition and chemical analyses of dietary
ingredients
Composition Concentrate Corn silage
Ingredient (% DM)
Corn ground 50.0
Soybean meal 43.9
Mineral and vitamin mix 3.5
Limestone 2.6
Chemical composition (% DM)
DM (%) 88.2 38.5
CP 22.6 8.2
NDF 24.6 64.4
ADF 15.8 34.2
ADIN 0.21 0.19
NDIN 0.49 0.23
Lignin 3.32 3.92
EE 4.1 3.9
DM = dry matter; CP = crude protein; ADIN = acid detergent-insoluble nitro-
gen; NDIN = neutral detergent-insoluble nitrogen; EE = ether extract.
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intake, and samples of corn silage (offered and orts) and
concentrate (offered) were taken weekly and frozen at −20°C
for chemical analysis. Goats were manually milked at 0500
and 1500 h and individual milk production was recorded daily
throughout the study. Pooled milk samples (from morning and
afternoon milkings) were collected in 30 ml tubes containing
bromopol (D & F Control System Inc., San Ramon, CA, USA) on
the 10th, 11th and 12th day of each treatment period to
determine its solids concentration (fat, protein and lactose)
and somatic cell count (SCC). These samples were stored at
4°C until analysis. The average milk composition of the 10th,
11th and 12th day, from each treatment period, was calcu-
lated and the values obtained were used in the statistical
analysis. A second milk sample was taken on the 12th day
of each treatment period and stored at −20°C without
preservative for analysis of the fatty-acid proﬁle. In addition,
body weight and BCS, scale 1 to 5 (Villaquiran et al., 2005),
were determined on the 12th day of each treatment period.
Blood samples were taken after afternoon milking on the
12th day of each treatment period, via jugular vein puncture,
using vacutainer tubes (Zhejiang Kangshi Medical Devices
Co., Hangzhou, China) containing ethylenediamine tetra-
acetic acid and placed on ice. Thereafter, samples were
centrifuged at 2800× g per 15 min and the resulting plasma
was stored in Eppendorf tubes and stored at −20°C until
analysis of glucose and non-esteriﬁed fatty-acid (NEFA)
concentrations.
Chemical analysis
The feed offered and orts were measured daily, sampled,
pooled weekly and analyzed for dry matter (DM), crude protein
(CP) and ether extract (EE; Association of Ofﬁcial Analytical
Chemists (AOAC) 2000). The analysis of the NDF, ADF, neutral
detergent-insoluble nitrogen (NDIN), acid detergent-insoluble
nitrogen (ADIN) and lignin were performed according to
Van Soest et al. (1991). Milk components (fat, protein and
lactose) were determined according to AOAC (2000), and SCC
by ﬂow cytometry. Glucose plasma levels were determined
through a direct reading (glucose oxidase enzyme immobilized
in membrane) in an automatic YSI 2007 analyzer (Bicochemistry
Analyzer, Yellow Springs, USA) and NEFA plasma concentration
was determined by colorimetric–enzymatic method (NEFA C;
Wako Pure Chemical Industries, Osaka, Japan) using a 96-well
microplate for ELISA.
The milk fatty acids were extracted according to Hara
and Radin (1978), using a 3 : 2 (v/v) mix of hexane and
isopropanol (18 ml/g of extracted fat) followed by a solution of
sodium sulfate 67 g/l (12 ml/g of extracted fat). Fatty-acid
methyl esters (FAME) were obtained by base-catalyzed trans-
methylation using a freshly prepared methylation reagent
(0.4 ml of 5.4 mol/l of sodium methoxide solution plus 1.75 ml
methanol). The esteriﬁcation of milk fatty acids was carried
out with an alkaline catalyst according to Christie (1982).
The mixture was neutralized with oxalic acid (1 g of oxalic
acid in 30 ml of diethyl ether (Chouinard et al., 1999)), and
calcium chloride was then added to remove methanol residue
(Christie, 1982). The FAME were determined using a gas
chromatograph (model 6890 N; Agilent Technologies, Barueri,
São Paulo, Brazil), equipped with ﬂame ionization detector and
fused silica capillary column CP-Sil 88 (100m× 25mm× 0.2
µm of ﬁlm thickness; Varian Inc., Mississauga, Canada).
Hydrogen was used as a carrier gas (1 ml/min) and nitrogen as
an auxiliary gas (30 ml/min). Detector and injector temperatures
were set at 250°C, with split ratio 20 : 1. Oven temperature was
set for 45°C for 4 min, increased by 13°C/min to 175°C, held for
27 min, increased by 4°C/min to 215°C and held for 35 min
(Cruz-Hernandez et al., 2007). The FAME were identiﬁed by
comparing three FAME references (Supelco37 mix # 47885-U,
linoleic acid isomers mix # 47791, and CLA isomers mix #
05632; Sigma Aldrich, São Paulo, São Paulo, Brazil). The
cis/trans-18:1 isomers were identiﬁed according to their order of
elution reported under the same chromatographic conditions
(Kramer et al., 2001; Cruz-Hernandez et al., 2007).
The fatty-acid proﬁle of CSFA was determined using the one-
step procedure described originally by Sukhija and Palmquist
(1988), with modiﬁcations (Palmquist and Jenkins, 2003).
Tridecanoic acid (C13:0) was used as an internal standard to
determine total fatty-acid concentration. To determine the
fatty-acid composition of the CLA-ME supplement, a 40 μl
sample was mixed with 2 ml of hexane and added to calcium
chloride (200 mg); the solution was vortexed and allowed to
rest for 1 h before being transferred to 2 ml vials. Chroma-
tographic conditions were the same as those previously
described for milk fatty-acid analysis.
Calculations
Desaturase indices were calculated for ﬁve fatty-acid
pairs (c9-14:1/14:0, c9-16:1/16:0, c9-17:1/17:0, c9-18:1/18:0
and c9,t11-CLA/t11-18:1), which represent a proxy for the
stearoyl-CoA desaturase enzyme (Δ9-desaturase) activity.
The indices were calculated according to the deﬁnition of
Kelsey et al. (2003), where: desaturase index = product/
(product+ substrate). The secretion of milk fatty acids, in
mmol/day, was calculated assuming that milk fat is com-
posed of 98% triacylglycerol, from which 95% are fatty acids
(Jensen, 2002). In addition, the molecular weight of each
fatty acid was adjusted for hydrogen and oxygen atoms
removed by the ester bond.
The EB was calculated for the last (12th) day of each
experimental period according to the following equation:
EB (Mcal/day) = metabolizable energy (ME) intake – (ME
maintenance (MEm)+ME lactation (MEl)). To obtain the
energy intake, feed total digestible nutrient (TDN) values
were obtained according to Weiss et al., (1992), and then
converted to ME through the following equation (NRC, 2007):
ME (Mcal/kg) = (1 kg of TDN = 4.4 Mcal of digestible
energy)× 0.82 and ME intake was determined by multiplying
the dry matter intake (DMI) by the ME of the diet compo-
nents (corn silage and concentrate) plus ME from the lipid
supplements (provided by the manufacturer): Luta-CLA 60
(8.8 Mcal of ME/kg), CSFA (7.1 Mcal of ME/kg). The ME
requirement for maintenance was calculated by the follow-
ing equation: MEm (Mcal/day) = 110 kcal× BW0.75. The ME
requirement for lactation was determined according to the
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NRC (1989) using an efﬁciency factor of ME utilization in the
diet for lactation, according to Nsahlai et al. (2004) by the
following equation: MEl (Mcal/day) = (Milk production×
(0.3512+ (0.0962×% fat in the milk)))/0.589.
Statistical analyses
The data were subjected to variance analysis for a replicated
4× 4 Latin Square design using the MIXED procedure of
Statistical Analysis System (SAS, 2002) according to the
following model:
Yijkl ¼ μ + Si +GjðiÞ +Tk +Pl + εijkl
where Yijkl is the individual observation, μ the overall mean,
Si the ﬁxed effect of square, Gj(i) the random effect of goat
within square effect, Tk the ﬁxed effect of treatment, Pl the
ﬁxed effect of period and εijkl the experimental error. The
interaction between treatment and square was tested;
however, it was not signiﬁcant and was removed from the
model. The sum of the treatment squares was decomposed
using orthogonal polynomial contrasts to test the signiﬁcance
of the linear, quadratic and cubic responses. The treatment
effects were considered signiﬁcant at P< 0.05.
The relationships between t10,c12-CLA found in milk
fat and the percentage and production of milk fat
were examined using the nonlinear least square regression
procedure (PROC NLIN), using the following model:
y ¼ β0 ´ eðβ1xÞ + c + ε, where y is the percentage or fat
production, x is the t10,c12-CLA concentration in the milk fat
and ε is the error term in the regression equation. The
parameters β0 and β1 represent, respectively, the scale and
rate of exponential decline, and c is the constant of the lower
asymptote. For the regressions, the data considered outliers
were removed.
Results
The animals consumed the entire daily portion of the
concentrate with the treatments and remained in good
conditions during all the experiments. Six values (two from
Control, two from CLA15, one from CLA30 and one from
CLA45) were removed (outliers) from the regression analysis
used to describe the relationship between milk fat t10,c12-
CLA content and milk fat secretion. Diet supplementation
with increasing doses of CLA had no effect on silage DMI and
BCS. Milk production, milk SCC, milk protein, and lactose
content and production did not differ (P> 0.05) among
treatments. On the other hand, the fat concentration and
production were linearly (P< 0.01) reduced with CLA sup-
plementation (Table 3). Compared with control, CLA15,
CLA30 and CLA45 reduced fat production by 14.9%, 30.8%
and 40.5%, and concentration by 17.2%, 33.1% and 40.7%,
respectively.
The milk fatty-acid proﬁle was modiﬁed by treatments
(Table 4). There was a linear (P< 0.01) reduction in the
proportion of fatty acids ⩽16 carbons, and a linear (P< 0.01)
increase in most fatty-acid ⩾17 carbons. Those originating
from de novo synthesis and C16 (derived from both de novo
synthesis and blood) were reduced by 6.9%, 15.0% and
18.7%, and 2.1%, 6.3% and 12.8% relative to the control,
for CLA15, CLA30 and CLA45, respectively (Table 5). In
contrast, milk fatty acids derived exclusively from blood
stream (>16C) increased by 6.2%, 12.6% and 17.2% in the
CLA15, CLA30 and CLA45 treatments, respectively (Table 5).
The t10,c12-CLA supplementation linearly (P< 0.01) reduced
the majority of the fatty-acid pairs representing desaturase
indices (Table 5). In relation to the control group, only
the c9,t11-CLA/t11-18:1 index was not affected (P> 0.05).
The t10,c12-CLA concentration in milk fat increased linearly
Table 3 Performance, milk production and composition of stall-fed dairy goats supplemented with CLA methyl esters
Treatment1 P-value2
CLA0 CLA15 CLA30 CLA45 s.e. L Q
Silage intake (kg/day) 0.85 0.86 0.82 0.84 0.04 0.73 0.92
BCS 2.75 2.75 2.72 2.78 0.06 0.83 0.34
Log SCC3 6.09 5.68 6.02 6.38 0.29 0.37 0.21
Production
Milk (kg/day) 2.32 2.37 2.41 2.35 0.07 0.67 0.50
Fat (g/day) 67.80 57.69 46.88 40.34 10.17 <0.01 0.54
Protein (g/day) 63.69 65.48 65.44 65.51 1.83 0.53 0.64
Lactose (g/day) 88.33 90.93 91.85 89.81 2.49 0.64 0.36
Concentration
Fat (%) 2.90 2.40 1.94 1.72 0.10 <0.01 0.19
Protein (%) 2.76 2.77 2.75 2.79 0.03 0.52 0.63
Lactose (%) 3.81 3.82 3.80 3.82 0.03 0.85 0.81
CLA = conjugated linoleic acid; BCS = body condition score; SCC = somatic cell count.
1The treatments corresponded to supplementation of 0, 15, 30 and 45 g/day of a supplement containing 29.9% of methyl ester of t10,c12-CLA (CLA0, CLA15, CLA30 and
CLA45, respectively).
2Probability values for the linear (L) and quadratic (Q) contrasts. Cubic effect was not signiﬁcant considering P> 0.05.
3Somatic cell count (log SCC = log2 (CCS/100.000)+ 3).
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(P< 0.01), representing 0.03 g/100g of milk fatty acids in
the control and 0.47 g/100g of milk fatty acids in the CLA45.
This increase in the t10,c12-CLA concentration and its rela-
tionship with the milk fat concentration and production is
showed in Figure 1.
Diet supplementation with CLA linearly reduced (P< 0.01)
the secretion of all milk fatty acids (mmol/day), with those
coming from de novo synthesis being more affected (Figure 2).
The secretion of t10,c12-CLA linearly increased (P< 0.01) from
0.09 for the control to 0.27, 0.46 and 0.67 mmol/day for
CLA15, CLA30 and CLA45, respectively. The apparent transfer
efﬁciency was not different (P> 0.05; 1.18%, 0.13 s.e.)
among treatments. The estimated EB for the 12th day was
linearly (P< 0.01) improved as CLA doses increased (Table 6).
Table 4 Milk fatty-acid proﬁle of stall-fed dairy goats supplemented with CLA methyl esters
Treatment1 P-value2
Fatty acid (g/100 g) CLA0 CLA15 CLA30 CLA45 s.e. L Q
4:0 2.87 3.05 2.96 2.79 0.07 0.30 0.07
6:0 2.31 2.05 1.80 1.60 0.05 <0.01 0.55
8:0 2.35 1.94 1.59 1.40 0.06 <0.01 0.09
10:0 7.63 6.44 5.36 4.82 0.20 <0.01 0.13
11:0 0.20 0.14 0.10 0.07 0.01 <0.01 0.01
12:0 3.50 3.08 2.68 2.61 0.11 <0.01 0.16
13:0 0.05 0.05 0.07 0.08 0.01 <0.01 0.18
14:0 8.59 8.7 8.58 8.67 0.29 0.91 0.97
c9-14:1 0.09 0.07 0.05 0.04 0.01 <0.01 0.34
15:0 0.52 0.57 0.58 0.64 0.02 <0.01 0.97
Iso-15:0 0.20 0.19 0.22 0.20 0.01 0.39 0.35
Anteiso-15:0 0.32 0.37 0.34 0.36 0.02 0.27 0.43
16:0 24.68 24.22 23.19 21.62 0.32 <0.01 0.11
c9-16:1 0.49 0.43 0.39 0.33 0.02 <0.01 0.96
17:0 0.38 0.39 0.42 0.42 0.01 0.12 0.76
c9-17:1 0.14 0.12 0.11 0.09 0.01 <0.01 0.82
18:0 12.83 15.39 17.52 19.07 0.49 <0.01 0.32
t4-18:1 0.03 0.04 0.04 0.03 0.01 0.44 0.06
t5-18:1 0.03 0.03 0.04 0.04 0.01 0.19 0.86
t6+t7+t8 18:1 0.21 0.26 0.30 0.28 0.02 <0.01 0.04
t9-18:1 0.30 0.34 0.43 0.42 0.02 <0.01 0.21
t10-18:1 0.54 0.92 1.21 1.40 0.04 <0.01 0.03
t11-18:1 1.27 1.52 2.10 2.21 0.13 <0.01 0.60
t12-18:1 0.48 0.61 0.72 0.82 0.04 <0.01 0.72
t13+t14 18:1 0.53 0.71 0.75 0.68 0.04 0.01 <0.01
c9+t15 18:1 18.70 17.60 16.59 16.4 0.63 0.07 0.48
t16-18:1 0.36 0.37 0.39 0.41 0.03 0.25 0.96
c11-18:1 1.38 1.23 1.28 1.34 0.07 0.80 0.18
c12-18:1 0.80 1.15 1.08 1.00 0.07 0.01 <0.01
c13-18:1 0.08 0.09 0.09 0.08 0.01 0.73 0.36
c9,t12-18:2 0.02 0.02 0.01 0.01 0.01 0.24 0.60
c9,c12-18:2 2.80 2.58 2.68 2.74 0.08 0.82 0.09
c9,t11-CLA 0.53 0.56 0.71 0.82 0.03 <0.01 0.15
t10,c12-CLA 0.03 0.14 0.29 0.47 0.02 <0.01 0.15
c9,c12,c15-18:3 0.15 0.14 0.13 0.13 0.01 <0.01 0.04
18:3n-3 0.01 0.01 0.007 0.005 0.003 0.01 0.67
20:0 0.21 0.23 0.24 0.24 0.01 <0.01 0.10
c11-20:1 0.04 0.04 0.05 0.05 0.01 <0.01 0.55
20:3n-6 0.02 0.02 0.02 0.03 0.01 0.35 0.18
20:4n-6 0.18 0.15 0.15 0.14 0.01 <0.01 0.69
22:0 0.04 0.05 0.06 0.05 0.01 <0.01 0.03
24:0 0.03 0.03 0.02 0.03 0.01 0.99 0.42
Others 3.91 3.90 4.61 5.32 0.20 <0.01 0.10
CLA = conjugated lenoleic acid.
1The treatments corresponded to supplementation of 0, 15, 30 and 45 g/day of a supplement containing 29.9% of methyl ester of t10,c12-CLA (CLA0, CLA15, CLA30 and
CLA45, respectively).
2Probability values for the linear (L) and quadratic (Q) contrasts. Cubic effect was not signiﬁcant considering P> 0.05.
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However, there was no effect (P> 0.05) from the increasing
doses of CLA on the circulating levels of glucose and NEFA
(Table 6).
Discussion
Feeding increasing doses of t10,c12-CLA had no effect on
silage DMI, BCS and plasma concentrations of glucose and
NEFA, which is consistent with previous experiments in cows
with a positive EB (Baumgard et al., 2002a; Kay et al. 2007).
Table 5 Milk fatty-acid proﬁle grouped by origin and desaturase indices of stall-fed dairy goats supplemented with CLA methyl esters
Treatment1 P-value2
g/100 g fatty acids CLA0 CLA15 CLA30 CLA45 s.e. L Q
Summation
< C16 28.66 26.67 24.35 23.30 0.66 <0.01 0.49
C16 25.17 24.65 23.57 21.95 0.35 <0.01 0.10
> C16 42.15 44.78 47.46 49.42 0.78 <0.01 0.67
Desaturase index3
14:1/14:0+14:1 0.01 0.009 0.006 0.005 0.001 <0.01 0.37
16:1/16:0+16:1 0.019 0.018 0.016 0.015 0.001 <0.01 0.96
17:1/17:0+17:1 0.27 0.24 0.21 0.18 0.01 <0.01 0.85
c9-18:1/18:0+c9-18:1 0.59 0.53 0.49 0.46 0.01 <0.01 0.18
CLA4 0.30 0.27 0.26 0.27 0.01 0.09 0.06
CLA = conjugated linoleic acid.
1The treatments corresponded to supplementation of 0, 15, 30 and 45 g/day of a supplement containing 29.9% of methyl ester of t-10,c-12-CLA (CLA0, CLA15, CLA30
and CLA45, respectively).
2Probability values for the linear (L) and quadratic (Q) contrasts. Cubic effect was not signiﬁcant considering P> 0.05.
3Product/(product+ substrate) ratio related to the Δ9-dessaturase enzyme.
4c9,t11-CLA/(c9,t11-CLA+ t11-18:1) ratio.
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Figure 1 Effect of the concentration of milk t10,c12-CLA on milk fat yield
(a, n = 26) and milk fat percentage (b, n = 32) of stall-fed dairy goats
supplemented with CLA methyl esters. CLA = conjugated linoleic acid.
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Figure 2 Milk fatty-acid secretion of stall-fed dairy goats supplemented
with t10,c12-CLA methyl esters, according to their origin: de novo synthesis
(<16 carbons), from blood (>16 carbons), and from both sources (16:0 and
16:1). The treatments corresponded to supplementation of 0, 15, 30 and
45 g/day of a supplement containing 29.9% of methyl ester of t10,c12-CLA
(CLA0, CLA15, CLA30 and CLA45, respectively). CLA = conjugated
linoleic acid.
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This lack of effect on plasma glucose and NEFA concentra-
tions may be because of the magnitude of the spared energy
associated with responsiveness of metabolic pathways.
However, the surplus of energy is sometimes accompanied
by an increase in the expression of lipogenic enzymes in the
adipose tissue, resulting in increased body reserve replenish-
ment (Harvatine et al., 2009).
The milk fat percentage showed a curvilinear relationship
with the percentage of milk t10,c12-CLA (Figure 1) being
observed also in other experiments on goats (Shingﬁeld
et al., 2009) and cows (de Veth et al., 2004). Assuming that
the digestion and absorption of t10,c12-CLA is the same
in goats and cows (Shingﬁeld et al., 2009), we used the
equation of de Veth et al. (2004) that shows the relationship
between milk fat t10,c12-CLA concentration and milk fat
yield to compare the magnitude of t10,c12-CLA-induced milk
fat depression between these two ruminant species. When
treatment means obtained from the current trial for t10,c12-
CLA concentration in milk fat from each treatment were used,
the reductions in milk fat production were 29.6%, 41.8%
and 46.5%, respectively, for CLA15, CLA30 and CLA45. This
difference in milk fat depression between species suggests an
inter-species difference for t10,c12-CLA effects, an assumption
raised by other studies (Lock et al., 2008; Shingﬁeld et al.,
2009). There are various reports on the scientiﬁc literature
indicating the inhibitory effects of the t10,c12-CLA on milk fat
synthesis in different ruminant species (de Veth et al., 2004;
Lock et al., 2006; Shingﬁeld et al., 2009), whereas milk
production and secretion of other milk components are
usually unchanged (Bauman et al., 2011).
In addition, a lower responsiveness of goats compared with
other ruminant species may be the adverse effects of t10,c12-
CLA on sheep observed by Oliveira et al. (2012). According
to those authors, the supplementation of 8.97 g/day of t10,
c12-CLA resulted in a decrease in milk production and on all
the other milk components with an increase in the SCC and
still, a complete termination of milk secretion by the animals.
The CLA supplement was the same and the dose of t10,c12-
CLA used by those authors corresponds to CLA30 treatment in
our study, and there was no detrimental effect even at the
largest dose (CLA45).
To compare our results with those reported in previous
studies on goats, the average values of milk fat t10,c12-CLA
observed in the present study were used in the equation
described by Shingﬁeld et al. (2010). By using this approach,
we observed that milk fat secretion was reduced by 14%,
23% and 28% in response to CLA15, CLA30 and CLA45,
respectively. The differences in the magnitude of milk fat
depression observed in the present study as compared
with values estimated from the equation of Shingﬁeld et al.
(2010) may result from the fact that most of the data used to
generate the above-mentioned equation were originated
from studies in which lipids were not fed as a dietary
supplement. Other aspect that could have inﬂuenced this
observation is a possible increase in milk fat by the control fatty
supplement, an effect that has been reported in the literature
(Chilliard et al., 2007), what could bring a bias for comparing
the CLA dose–response with CLA0. The inclusion of a lipid
supplement in the control treatment was done to have iso-
energetic experimental diets. Although the amount of unsatu-
rated fatty acids supplied in the control diet is not negligible,
studies on goats (Chilliard et al., 2007) reported only a minor
formation of ruminal biohydrogenation intermediates.
The t10,c12-CLA isomer has demonstrated inhibition on
the gene expression of the stearoyl-CoA desaturase enzyme
(Baumgard et al., 2002b) and, in vivo, the enzyme activity on
the mammary gland can be estimated through the product/
substrate ratio of some fatty-acid pairs under its action
(Bernard et al., 2008). The absence of effect on c9,t11-CLA/
t11-18:1 ratio index could be because of the presence of the
c9,t11-CLA isomer in the CLA supplement. While evaluating
other indices, we observed that the dose of t10,c12-CLA that
most effectively caused a reduction began with the CLA30
treatment. This result corroborates earlier studies on dairy
goats (Lock et al., 2008; Shingﬁeld et al., 2009) and dairy
cows (Perﬁeld et al., 2006), where small doses of t10,c12-
CLA, despite causing a reduction in milk fat, do not affect the
desaturation of fatty acids in the mammary gland. In this
study, the only index that presented a reduction in the CLA15
treatment was 18:1/18:0; however, this response should
be regarded with caution, because it could just be a con-
sequence of the presence of oleic acid (c9-18:1) in the lipid
supplement used.
The secretion of the majority of milk fatty acids was
affected by t10,c12-CLA. Increased doses resulted in less
fatty acids from de novo synthesis and those preformed in
milk, but the former were more affected. This observation is
consistent with the data reported on cows (de Veth et al.,
2004) and goats (Lock et al., 2008) and partially contrasts
with those observed by Shingﬁeld et al. (2009), who reported
a reduction in the secretion of only the fatty acids coming
from de novo synthesis, whereas the preformed were not
affected by the treatments.
Despite their potential rumen biohydrogenation, t10,
c12-CLA and t10-18:1 were the only fatty acids that did not
have their secretion reduced by the increased doses of
Table 6 EB, NEFA and blood glucose concentration of stall-fed dairy
goats supplemented with CLA methyl esters
Treatment 1 P-value2
CLA0 CLA15 CLA30 CLA45 s.e. L Q
EB3 (Mcal/day) 0.52 0.72 0.89 1.05 0.12 <0.01 0.87
NEFA (µmol/l) 0.54 0.49 0.51 0.45 0.03 0.06 0.99
Glucose (mg/l) 60.72 60.72 61.64 61.98 1.34 0.44 0.90
EB = energy balance; NEFA = non-esteriﬁed fatty acids; CLA = conjugated
linoleic acid.
1The treatments corresponded to supplementation of 0, 15, 30 and 45 g/day of a
supplement containing 29.9% of methyl ester of t-10,c-12-CLA (CLA0, CLA15,
CLA30 and CLA45, respectively).
2Probability values for the linear (L) and quadratic (Q) contrasts. Cubic effect was
not signiﬁcant considering P> 0.05.
3EB = metabolizable energy intake− (metabolizable energy for maintenance+
metabolizable energy for lactation).
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t10,c12-CLA. The increase in the t10,c12-CLA secretion
reﬂects the increase in the doses supplied. Nevertheless,
the transfer efﬁciency of the doses was lower than those
reported by other studies involving the use of t10,c12-CLA in
the diets of goats (Lock et al., 2008; Shingﬁeld et al., 2009)
and cows (de Veth et al., 2004). This lower transfer efﬁciency
was expected, as the form of supplementation used did not
permit any protection against ruminal metabolism of the
lipids, unlike the studies previously mentioned.
Conclusions
Feeding increasing doses of unprotected t10,c12-CLA-ME
reduced both milk fat content and secretion, and improved
the EB in dairy goats. The t10,c12 CLA-induced milk fat
depression was accompanied by reduction in the secretion of
milk fatty acids from all chain lengths, with those arising
from de novo pathway being more affected as the CLA dose
increased. As a consequence, the concentration of ⩽16C
fatty acids in milk fat was reduced accordingly. Inter-species
comparisons of the relationship between the milk fat t10,
c12-CLA concentration and the magnitude of the milk fat
depression suggest a lower sensitivity to this CLA isomer in
goats as compared with cows and ewes.
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